The molecular bases of restenosis

被引:128
作者
Libby, P
Tanaka, H
机构
[1] Cardiovascular Division, Dept of Medicine, Brigham and Women's Hospital, Boston, MA 02115
关键词
D O I
10.1016/S0033-0620(97)80002-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies on the fundamental mechanisms of restenosis after arterial intervention have undergone upheaval. The rat carotid artery has provided perhaps the most widely used experimental preparation for the study of the response to acute arterial injury and gave rise to the multiwave model of restenosis. However, simple arterial injury differs substantially from angioplasty to diseased human vessels. The human intimal lesion already contains abundant smooth muscle cells and leukocytes. Therefore, although the rat carotid injury preparation has provided keen insight into the biology of the response to injury, it mimics human restenosis poorly, if at all. The first wave and second wave of the response to arterial injury so well delineated in rats (medial smooth muscle cell proliferation and migration from media into intima) may not apply to clinical angioplasty injury at all. Smooth muscle proliferation, a constant in injury to animal arteries, may be indolent in human restenosis. Accumulation of extracellular matrix probably explains in part the dissociation between intimal thickening and smooth muscle replication. Also, failure to 'remodel' outwards to maintain the increased caliber produced by interventional arterial dilatation, may prove more important than intimal thickening in determining ultimate intimal caliber. Despite a rather disappointing decade of translation of laboratory findings to the clinic, some grounds for optimism in approaching the complications of arterial intervention have emerged. Our appreciation for the biological complexities underlying the restenosis problem have increased. In interventional cardiology we can now proceed, more experienced and wiser, to longer range solutions to help our patients based on mechanistic insights.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 53 条
  • [1] CYTOKINES AND GROWTH-FACTORS POSITIVELY AND NEGATIVELY REGULATE INTERSTITIAL COLLAGEN GENE-EXPRESSION IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS
    AMENTO, EP
    EHSANI, N
    PALMER, H
    LIBBY, P
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (05): : 1223 - 1230
  • [2] Andersen HR, 1996, CIRCULATION, V93, P1716
  • [3] AN ACTIVATED FORM OF TRANSFORMING GROWTH FACTOR-BETA IS PRODUCED BY COCULTURES OF ENDOTHELIAL-CELLS AND PERICYTES
    ANTONELLIORLIDGE, A
    SAUNDERS, KB
    SMITH, SR
    DAMORE, PA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) : 4544 - 4548
  • [4] FOLGEN DES GEFASSKATHETERISMUS AM NORMO- UND HYPERCHOLESTERINAEMISCHEN KANINCHEN
    BAUMGART.HR
    STUDER, A
    [J]. PATHOLOGIA ET MICROBIOLOGIA, 1966, 29 (04): : 393 - &
  • [5] Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury
    Bendeck, MP
    Irvin, C
    Reidy, MA
    [J]. CIRCULATION RESEARCH, 1996, 78 (01) : 38 - 43
  • [6] SMOOTH-MUSCLE CELL-MIGRATION AND MATRIX METALLOPROTEINASE EXPRESSION AFTER ARTERIAL INJURY IN THE RAT
    BENDECK, MP
    ZEMPO, N
    CLOWES, AW
    GALARDY, RE
    REIDY, MA
    [J]. CIRCULATION RESEARCH, 1994, 75 (03) : 539 - 545
  • [7] PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE
    CARMELIET, P
    SCHOONJANS, L
    KIECKENS, L
    REAM, B
    DEGEN, J
    BRONSON, R
    DEVOS, R
    VANDENOORD, JJ
    COLLEN, D
    MULLIGAN, RC
    [J]. NATURE, 1994, 368 (6470) : 419 - 424
  • [8] PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .2. EFFECTS ON HEMOSTASIS, THROMBOSIS, AND THROMBOLYSIS
    CARMELIET, P
    STASSEN, JM
    SCHOONJANS, L
    REAM, B
    VANDENOORD, JJ
    DEMOL, M
    MULLIGAN, RC
    COLLEN, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2756 - 2760
  • [9] PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .1. GENERATION BY HOMOLOGOUS RECOMBINATION AND CHARACTERIZATION
    CARMELIET, P
    KIECKENS, L
    SCHOONJANS, L
    REAM, B
    VANNUFFELEN, A
    PRENDERGAST, G
    COLE, M
    BRONSON, R
    COLLEN, D
    MULLIGAN, RC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2746 - 2755
  • [10] TRANSGENIC ANIMALS AS TOOLS FOR THE STUDY OF FIBRINOLYSIS IN-VIVO
    CARMELIET, P
    MULLIGAN, RC
    COLLEN, D
    [J]. JOURNAL OF INTERNAL MEDICINE, 1994, 236 (04) : 455 - 459